Literature DB >> 11095860

Influenza: New Insights Into an Old Disease.

.   

Abstract

In the United States each year, influenza accounts for an estimated 20,000 to 40,000 deaths, nearly 300,000 hospitalizations, and millions of days lost from work. In the past few years, there has been an explosion of information in the medical literature related to influenza. This paper reviews these latest developments that enhance our understanding of influenza epidemiology and virology and expand our prevention and treatment options. Diminishing the impact of influenza in this country will require continued intense surveillance, increased use of influenza vaccine, and the availability of alternative vaccines and antivirals with the potential for broader protection against shift-and-drift strains of influenza.

Year:  2000        PMID: 11095860     DOI: 10.1007/s11908-000-0039-3

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  43 in total

1.  Predicting the evolution of human influenza A.

Authors:  R M Bush; C A Bender; K Subbarao; N J Cox; W M Fitch
Journal:  Science       Date:  1999-12-03       Impact factor: 47.728

2.  New recommendation for adult immunization.

Authors:  C Marwick
Journal:  JAMA       Date:  1999-12-15       Impact factor: 56.272

3.  Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group.

Authors: 
Journal:  Lancet       Date:  1998-12-12       Impact factor: 79.321

Review 4.  Emerging infections: pandemic influenza.

Authors:  W P Glezen
Journal:  Epidemiol Rev       Date:  1996       Impact factor: 6.222

5.  Influenza and the rates of hospitalization for respiratory disease among infants and young children.

Authors:  H S Izurieta; W W Thompson; P Kramarz; D K Shay; R L Davis; F DeStefano; S Black; H Shinefield; K Fukuda
Journal:  N Engl J Med       Date:  2000-01-27       Impact factor: 91.245

6.  Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

Authors:  F G Hayden; A D Osterhaus; J J Treanor; D M Fleming; F Y Aoki; K G Nicholson; A M Bohnen; H M Hirst; O Keene; K Wightman
Journal:  N Engl J Med       Date:  1997-09-25       Impact factor: 91.245

7.  Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus.

Authors:  K Y Yuen; P K Chan; M Peiris; D N Tsang; T L Que; K F Shortridge; P T Cheung; W K To; E T Ho; R Sung; A F Cheng
Journal:  Lancet       Date:  1998-02-14       Impact factor: 79.321

8.  Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections.

Authors:  A S Monto; D M Fleming; D Henry; R de Groot; M Makela; T Klein; M Elliott; O N Keene; C Y Man
Journal:  J Infect Dis       Date:  1999-08       Impact factor: 5.226

Review 9.  The next influenza pandemic: lessons from Hong Kong, 1997.

Authors:  R Snacken; A P Kendal; L R Haaheim; J M Wood
Journal:  Emerg Infect Dis       Date:  1999 Mar-Apr       Impact factor: 6.883

10.  The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.

Authors:  T Lasky; G J Terracciano; L Magder; C L Koski; M Ballesteros; D Nash; S Clark; P Haber; P D Stolley; L B Schonberger; R T Chen
Journal:  N Engl J Med       Date:  1998-12-17       Impact factor: 91.245

View more
  1 in total

1.  Transcriptome analysis of age-, gender- and diet-associated changes in murine thymus.

Authors:  Ana Lustig; Ashani T Weeraratna; William W Wood; Diane Teichberg; Dorothy Bertak; Arnell Carter; Suresh Poosala; Jeffrey Firman; Kevin G Becker; Alan B Zonderman; Dan L Longo; Dennis D Taub
Journal:  Cell Immunol       Date:  2007-05-17       Impact factor: 4.868

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.